[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633572":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":18,"locations":28,"responsibleParty":54,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":64,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":80,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"University of Maryland, Baltimore","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Study Population 1",null,"This study population will consist of individuals who have a diagnosis of pancreatic cancer and have not received chemotherapy treatment for their pancreatic cancer. Individuals who have received surgical resection and\u002For radiation therapy for their pancreatic cancer will be included.",{"label":13,"type":10,"description":14,"interventionNames":10},"Study Population 2","This study population will consist of individuals who have a diagnosis of pancreatic cancer and have received chemotherapy treatment for their pancreatic cancer. All stages of pancreatic cancer will be included including individuals in remission.",{"label":16,"type":10,"description":17,"interventionNames":10},"Study Population 3","This study population will consist of individuals who are at high risk of developing pancreatic cancer.",[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Jennifer Emel, MA","CONTACT","410-553-8048","Jennifer.Emel@umm.edu",{"name":25,"role":21,"phone":26,"phoneExt":10,"email":27},"Sade Bademosi","410-553-8188","Sade.Bademosi@umm.edu",[29],{"facility":30,"status":10,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"University of Maryland Baltimore Washington Medical Center","Glen Burnie","Maryland","21061","United States","US",{"type":37,"coordinates":38},"Point",[39,40],-76.62469,39.16261,{"lat":40,"lon":39},[43,47,50,52],{"name":44,"role":21,"phone":45,"phoneExt":10,"email":46},"Peter Olivieri, MD","410-553-8241","polivieri@umm.edu",{"name":48,"role":49,"phone":10,"phoneExt":10,"email":10},"Jeffrey Marshall, MD","SUB_INVESTIGATOR",{"name":51,"role":49,"phone":10,"phoneExt":10,"email":10},"Harvinder Singh, MD",{"name":53,"role":49,"phone":10,"phoneExt":10,"email":10},"Agazi Gebreselassie, MD",{"type":55,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Peter Olivieri","Chair, Division of Pulmonary & Critical Care; Director, Interventional Pulmonary Program",[59],{"name":60,"class":61},"EPOCH Epigenetics, Inc","UNKNOWN","100633572","signature-development-and-validation-protocol-for-an-epigenetic-assay-in-diagnosing-pancreatic-cancer-100633572",false,"NCT07528430","Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer","Inclusion Criteria:\n\n* 18 years old or older\n* Patient of UMMS\n* Willing and able to consent to study procedures listed in the protocol\n* Ability to speak and understand English\n* Has a history of pancreatic cancer of is at high risk for pancreatic cancer\n\nExclusion Criteria:\n\n* Younger than 18 years old\n* Patient not cared for at UMMS\n* Unable to consent to study procedures listed in the protocol\n* Unable to speak or understand English\n* Does not have a history of pancreatic cancer or is not at high risk for pancreatic cancer","ALL","18 Years",{"count":71,"type":72},450,"ESTIMATED","OBSERVATIONAL","The purpose of this research study is to test a new process for diagnosing pancreatic cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future.\n\nParticipants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.",[76],"Pancreatic Cancer, Advanced or Metastatic",[78,79],"Pancreatic cancer","Pancreatic cancer screening","NOT_YET_RECRUITING","2026-04-07",{"date":83,"type":84},"2026-04-14","ACTUAL",{"date":86,"type":72},"2026-05-01",{"date":88,"type":72},"2032-07",{"name":5,"class":6},1]